Create SD Holdings Co., Ltd. AI Stock Analysis
Want to see JP:3148 full AI Analyst Report?
Create SD Holdings Co., Ltd. (3148) AI Stock Analysis
Create SD Holdings Co., Ltd.
(TSE/TYO:3148)
The score is driven primarily by strong financial stability (notably the very conservative balance sheet) and supportive valuation (moderate P/E and ~3% dividend yield). These positives are offset by weak technicals, with the stock trading below key moving averages and negative momentum indicators, which weighs on the near-term outlook.
Create SD Holdings Co., Ltd. (3148) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 209.96B
- Dividend Yield
- 2.89%
- Average Volume (3M)
- 96.24K
- Price to Earnings (P/E)
- 12.5
- Beta (1Y)
- 0.10
- Revenue Growth
- 8.67%
- EPS Growth
- 3.24%
- Country
- Japan
- Employees
- 5,475
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Pharmaceuticals
Create SD Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
Create SD Holdings Co., Ltd., along with its various subsidiaries, conducts business in Japan across the drugstore, pharmacy, and nursing care sectors. Its retail operations provide a broad array of products, including pharmaceuticals, cosmetics, foo...
How the Company Makes Money
The company makes money primarily through retail sales generated at its drugstore operations. Its core revenue stream is the sale of pharmaceuticals, including (1) prescription drugs dispensed at in-store pharmacies (where revenue is driven by prescr...
Create SD Holdings Co., Ltd. Financial Statement Overview
Summary
Strong balance-sheet resilience (very low leverage and steadily growing equity) supports a high financial score. Income statement trends show solid multi-year revenue growth with stable, but modest, profitability; however, gross margin has compressed and free cash flow conversion has been volatile and only moderate versus net income, tempering the overall financial strength.
Income Statement
78PositiveBalance Sheet
90Very PositiveCash Flow
62Positive| Breakdown | TTM | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 497.13B | 497.13B | 457.09B | 422.33B | 380.96B | 350.74B |
| Gross Profit | 123.74B | 120.87B | 119.22B | 110.19B | 102.99B | 95.58B |
| EBITDA | 31.46B | 30.53B | 27.66B | 24.35B | 23.01B | 22.02B |
| Net Income | 16.99B | 16.99B | 15.69B | 13.69B | 12.93B | 12.60B |
Balance Sheet | ||||||
| Total Assets | 255.35B | 255.35B | 236.56B | 216.48B | 194.94B | 176.91B |
| Cash, Cash Equivalents and Short-Term Investments | 37.10B | 37.10B | 37.75B | 38.21B | 37.53B | 42.07B |
| Total Debt | 1.36B | 1.36B | 0 | 1.00M | 6.00M | 25.00M |
| Total Liabilities | 101.03B | 101.03B | 93.84B | 86.24B | 78.53B | 70.58B |
| Stockholders Equity | 154.32B | 154.32B | 142.72B | 130.24B | 116.41B | 106.32B |
Cash Flow | ||||||
| Free Cash Flow | 9.22B | 9.22B | 6.10B | 5.26B | 3.03B | 8.63B |
| Operating Cash Flow | 25.43B | 25.43B | 23.63B | 21.03B | 18.98B | 16.10B |
| Investing Cash Flow | -20.41B | -20.41B | -20.70B | -20.21B | -20.49B | -10.81B |
| Financing Cash Flow | -5.68B | -5.68B | -3.39B | -140.00M | -3.03B | -2.91B |
Create SD Holdings Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3148, the sentiment is Negative. The current price of 3220.00 is above the 20-day moving average (MA) of 3208.50, below the 50-day MA of 3262.20, and below the 200-day MA of 3264.70, indicating a neutral trend. The MACD of 3.52 indicates Negative momentum. The RSI at 49.48 is Neutral, neither overbought nor oversold. The STOCH value of 61.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3148.
Create SD Holdings Co., Ltd. Peers Comparison
Overall Rating
JP:339181Outperform
JP:764969Neutral
JP:998969Neutral
JP:314868Neutral
JP:354962Neutral
JP:334959.9Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 81Outperform | JPY 1.13T | 19.41 | 7.13% | 1.91% | ― | ― | |
| 69Neutral | JPY 528.15B | 16.79 | 9.94% | 1.30% | 8.97% | -29.54% | |
| 69Neutral | JPY 452.96B | 14.37 | 11.15% | 3.43% | 4.32% | 0.18% | |
| 68Neutral | JPY 205.78B | 12.45 | ― | 2.89% | 8.67% | 3.24% | |
| 62Neutral | JPY 486.01B | 25.22 | ― | 0.29% | 12.54% | 15.87% | |
| 60Neutral | JPY 502.83B | 15.48 | ― | 1.31% | 8.99% | 3.61% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:3148 | Create SD Holdings Co., Ltd. | 3220.00 | 63.26 | 2.00% | |
| JP:9989 | Sundrug Co | 3848.00 | -263.45 | -6.41% | |
| JP:7649 | Sugi Holdings Co | 1345.00 | -419.08 | -23.76% | |
| JP:3391 | TSURUHA Holdings | 2455.50 | -241.32 | -8.95% | |
| JP:3349 | COSMOS Pharmaceutical Corporation | 6236.00 | -1078.62 | -14.75% | |
| JP:3549 | KUSURI NO AOKI HOLDINGS CO.,LTD. | 5084.00 | 1137.96 | 28.84% |
Create SD Holdings Co., Ltd. Corporate Events
Create SD Holdings posts higher sales but lower Q1 profit, keeps outlook and dividend forecast
Create SD Holdings reported consolidated net sales of ¥129.54 billion for the three months ended August 31, 2026, up 6.5% year on year, while operating profit slipped 4.1% to ¥5.40 billion and profit attributable to owners of parent fell 5.2% to ¥3.7...
Create SD Holdings Details Controlling Shareholder Structure and Minority Protection Measures
Create SD Holdings Co., Ltd., listed on the Prime Market of the Tokyo Stock Exchange, is majority-controlled by Yohei Yamamoto and Director and Chairman Hisao Yamamoto through a combined 55.18 percent of voting rights. This ownership structure places...
Create SD Holdings Sets Director Slate and Post-Meeting Governance Structure
Create SD Holdings Co., Ltd. announced that its Board of Directors has approved the re-election of Representative Director and Chairman Hisao Yamamoto, Representative Director and President Taizo Hirose, and Director Yukihiko Takiya as director candi...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 14, 2026
